StockGlow

Halozyme Therapeutics, Inc. (0J2O.L)

Halozyme Therapeutics, Inc., a biopharmaceutical company, researches, develops, and commercializes of proprietary enzymes and devices in the United States, Switzerland, Belgium, Japan, and internationally.

$83.09-0.00%
Compare 0J2O.L with
StockGlow Score
95
Bullish
BearishBullish
1 year ago+41.5%

The outlook

Halozyme Therapeutics, Inc. currently reads as bullish based on above its 50- & 200-day averages, 96% of the way from its 52-week low to high. This is a snapshot of current market data, not a forecast.

What’s behind the score

Price trendAbove its 50- & 200-day averages
52-week range96% of the way from its 52-week low to high
Market cap
—
52-wk high
$85.19
52-wk low
$30.09
50-day avg
$36.88
200-day avg
$37.43
Trailing P/E
0.3

Similar stocks

0HKE.LAxon Enterprise, Inc.$525.23+0.90%0K6R.LNeurocrine Biosciences, Inc.$183.50+1.86%0JYM.LMarkel Group Inc.$1,884.83-7.19%0NC5.LInvestor AB (publ)$406.30+1.05%0JVT.Llululemon athletica inc.$120.50+1.58%

The StockGlow Score is a snapshot of current, observable market data (analyst ratings, price trend, 52-week range) — not a prediction, forecast, or recommendation. Informational only, not investment advice. Data from public sources and may be delayed. How this works·Privacy